OBI Pharma, Inc. is a biotechnology company specializing in the research and development of innovative cancer therapies. Founded in 2002 and headquartered in Taipei, Taiwan, OBI Pharma operates as a g... OBI Pharma, Inc. is a biotechnology company specializing in the research and development of innovative cancer therapies. Founded in 2002 and headquartered in Taipei, Taiwan, OBI Pharma operates as a global clinical-stage oncology firm with subsidiaries in the United States and Australia. Its core mission is to create novel therapeutic agents that address unmet medical needs in oncology, particularly through the development of "first-in-class" and "best-in-class" drug candidates. The company has a robust pipeline of products in various stages, including investigational therapies for triple-negative breast cancer, non-small cell lung cancer, hepatocellular carcinoma, and solid tumors. Recognized for its cutting-edge work in antibody-drug conjugates (ADC) and immunotherapy, OBI Pharma has received industry awards highlighting the promise of its technology and research platforms. Beyond oncology, OBI Pharma is engaged in the manufacture, wholesale, and global licensing of pharmaceutical products, contributing to advancements in the broader biotechnology and healthcare sectors. The company prioritizes both scientific excellence and international growth, reinforcing Taiwan’s emerging presence in global pharmaceutical innovation.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

OBI Pharma is not subject to EU Taxonomy reporting

Based on current regulatory requirements, OBI Pharma is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review OBI Pharma's data?

Start your 30-day free trial to request a data review for OBI Pharma.

Start Free Trial

Legal Center Contact Us